InvestorsObserver
×
News Home

Do Analysts Agree Monday on Sorrento Therapeutics Inc (SRNE) Stock's Target Price?

Monday, November 29, 2021 03:39 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Monday on Sorrento Therapeutics Inc (SRNE) Stock's Target Price?

InvestorsObserver is giving Sorrento Therapeutics Inc (SRNE) an Analyst Rating Rank of 74, meaning SRNE is ranked higher by analysts than 74% of stocks. The average price target for SRNE is $26.666 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating SRNE a Strong Buy today. Find out what this means to you and get the rest of the rankings on SRNE!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Sorrento Therapeutics Inc Stock Today?

Sorrento Therapeutics Inc (SRNE) stock is trading at $5.97 as of 3:34 PM on Monday, Nov 29, a gain of $0.03, or 0.52% from the previous closing price of $5.94. Volume today is 4,742,822 compared to average volume of 4,669,187. The stock has traded between $5.90 and $6.17 so far today. Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App